Nicola Marino, Director of AEON Foundation, on t
Author: Michael
Junevity founder explains how developments in si
Startup leverages cultivated muscle tissue gener
Company demonstrates treatment with intravenous
Professionals across insurance, pensions and res
Plasma biomarker measuring tau tangles aids diag
Company’s ‘precise and reversible’ RNA-edi
Company’s ‘precise and reversible’ RNA-edi
Rejuve Longevity users can monetize their health
Company to expand multi-ancestry biobank to supp